Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 862 results for "mylan"

Mylan N.V. (MYL) Short Interest Down 12.1% in December
American Banking News

FDA Accepts BLA for Breast Cancer Biosimilar Treatment

The FDA has acceptedthe biologics license application for Mylan's proposed biosimilar trastuzumab, for filing through the 351(k) pathway. MYL-14010 is designed to treat certain types of human epidermal growth factor receptor 2 (HER2) positive breast ... Pharmacy Times, 20 hours ago

1,704 images for mylan

SleekMoney, 3 hours ago
SleekMoney, 3 hours ago
Yahoo! Finance UK and Ireland, 1 day ago
Yahoo! India, 1 day ago
4 Traders, 1 day ago
Reuters, 1 day ago, 1 day ago
American Banking News, 1 week ago
FierceHealthPayer, 4 days ago
ITechPost, 12 hours ago

House Oversight Committee Holds Hearing On Rising Price Of EpiPens With Mylan Inc. CEO Heather Bresch

Science WASHINGTON, DC - SEPTEMBER 21: Mylan Inc. CEO Heather Bresch holds up a 2-pack of EpiPen as she testifies during a hearing before the House Oversight and Government Reform Committee September 21, 2016 on Capitol Hill in Washington, DC. The ...
 ITechPost12 hours ago Mylan CEO Bresch learned from EpiPen furor, hopes Trump appreciates 'decisive action' on pricing  CNBC1 week ago

Mylan's Biggest EpiPen Competitor Is Back

 USA Today1 day ago EpiPen competitor Auvi-Q comes back Feb. 14  CNBC2 days ago Kaleo undeterred by Mylan's trevails over EpiPen pricing; employing same controversial pricing strategy for Auvi-Q  Seeking Alpha2 days ago EpiPen gets a new rival: Auvi-Q. Its pricing scheme will blow your min …  Yahoo! Xtra Business1 day ago

CMS admin: Government has 'no settlement' with Mylan

Last fall, Mylan announced it had reached a swift settlement with the U.S. Department of Justice over allegedMedicaid misclassifications on thebig-selling EpiPen. But now, a top U.S. health official says there's no such deal, adding yet another ...
 FiercePharma1 day ago Slavitt: No settlement yet in EpiPen lawsuit  Health Leaders1 day ago MYLAN : U.S. health agency tells Grassley there is no EpiPen settlement yet  4 Traders1 day ago Epinephrine Auto-Injectors for Anaphylaxis  Journal of the American Medical Association4 days ago

CVS Health Corp (CVS) Goes After Mylan NV (MYL) With Cheaper Generic EpiPen

CVS Health Corp (ticker: CVS) is gearing up for a fight with Mylan NV (MYL) on drug pricing, offering a cheaper generic option of Mylan's EpiPen that's nearly one-sixth the cost. This follows intense scrutiny from both Congress and President-elect ...
 US News & World Report1 week ago Mylan launches generic EpiPen  GaBi Online1 week ago Mylan launches EpiPen generic at $300 per two-pack  Reuters1 month ago CVS Health goes ex-dividend today  Seeking Alpha1 day ago

Thu: Pharma stocks pull TASE down

Teva, Mylan and Perrigo were among the most notable decliners today. Insurance stocks were firm. The Tel Aviv Stock Exchange fell today. The Tel Aviv 25 Index fell 0.59%, to 1,450.06 points; the Tel Aviv 100 Index fell 0.58%, to 1,269.08 points; ...
 Globes1 week ago GOLDMAN SACHS: 13 stocks that could explode  InBusiness.ae1 week ago

CVS Health to sell Impax Labs' generic epinephrine autoinjector for $109.99

With the aim of addressing customers' anger over the high price of Mylan's (NASDAQ: MYL ) EpiPen (epinephrine injection, USP), CVS Health (NYSE: CVS ) says its pharmacies will sell a generic version of Amedra Pharmaceuticals' Adrenaclick , made by ...
 Seeking Alpha1 week ago CVS Health Offers Patients Lowest Cash Price in the Market for Generic Epinephrine Autoinjector to Treat Allergic Reactions  Pharma Focus Asia1 week ago CVS pharmacies have made available a less-expensive generic epinephrine autoinjector -- an alternative to the costly EpiPen from Mylan, the chain said.  TickerTech.com1 week ago CVS offers generic epinephrine injector at 'market-best' price; Cigna drops EpiPen  UPI1 week ago

EpiPen maker set to lose $800mn in 2017 as CVS & major insurer turn to rivals

Mylan, the controversial EpiPen maker, could lose much of the gains it made by hiking up the price of the lifesaving epinephrine auto-injector. Pharmacy chain CVS and insurance company Cigna have both announced they will turn toward the company's ...
 Russia Today1 week ago

Mylan Crushed By Trump, Cigna and CVS -- All In Two Days

 TheStreet.com1 week ago

CVS Is the Latest to Rock Mylan's EpiPen Empire

 TheStreet.com1 week ago Exclusive: EpiPen price hikes add millions to Pentagon costs  Reuters2 months ago Sick of $600 EpiPen Prices? A Major Retailer Has an Alternative for Only $10  Time1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less